>   Publications   >   Selective deletion of zinc transporter 3 in amacrine cells promotes retinal ganglion cell survival and optic nerve regeneration after injury
OptoDrum
Publication
April 17, 2024 • ✎ STRIA TECH

Selective deletion of zinc transporter 3 in amacrine cells promotes retinal ganglion cell survival and optic nerve regeneration after injury

Selective deletion of zinc transporter 3 in amacrine cells promotes retinal ganglion cell survival and optic nerve regeneration after injury

Publication

Neural Regeneration Research (Dec 01, 2023) Selective deletion of zinc transporter 3 in amacrine cells promotes retinal ganglion cell survival and optic nerve regeneration after injury
Liu Z, Xue J, Liu C, Tang J, Wu S, Lin J, Han J, Zhang Q, Wu C, Huang H, Zhao L, Zhuo Y, Li Y
DOI: 10.4103/1673-5374.373660 >>
This study investigates the role of zinc (Zn²⁺) in optic nerve regeneration after injury, focusing on its release from amacrine cells. Researchers created transgenic mouse models where zinc transporter 3 (ZnT3) was conditionally knocked out in amacrine cells or retinal ganglion cells. They found that Zn²⁺ released by amacrine cells triggers transcriptomic changes in retinal ganglion cells, influencing neuronal survival and axonal regeneration. Selective deletion of ZnT3 in amacrine cells improved retinal ganglion cell survival, axonal regeneration, and visual function recovery after optic nerve injury. The OptoDrum was used to measure visual acuity, demonstrating that the selective manipulation of Zn²⁺ release contributed to improved vision recovery outcomes.